These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24877124)

  • 21. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
    Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of xanthine oxidase activity with oxidative and inflammatory renal damage in silver catfish experimentally infected with Streptococcus agalactiae: Interplay with reactive oxygen species and nitric oxide.
    Souza CF; Baldissera MD; Moreira KLS; da Rocha MIUM; da Veiga ML; Santos RCV; Baldisserotto B
    Microb Pathog; 2017 Oct; 111():1-5. PubMed ID: 28804017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
    Gul A; Zager P
    Curr Diab Rep; 2018 Mar; 18(4):18. PubMed ID: 29497863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?
    Schuchardt M; Herrmann J; Tolle M; van der Giet M
    Curr Pharm Des; 2017; 23(23):3391-3404. PubMed ID: 28413972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to target uric acid to retard CKD progression.
    Kumagai T; Ota T; Tamura Y; Chang WX; Shibata S; Uchida S
    Clin Exp Nephrol; 2017 Apr; 21(2):182-192. PubMed ID: 27339448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
    Chen CC; Hsu YJ; Lee TM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1107-17. PubMed ID: 21622823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function.
    Bove M; Cicero AFG; Borghi C
    Curr Hypertens Rep; 2017 Oct; 19(12):95. PubMed ID: 29071435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats.
    Huijuan W; Xiaoxu C; Rui S; Xinghui L; Beibei T; Jianchun M
    Biomed Pharmacother; 2017 Jul; 91():358-365. PubMed ID: 28463799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
    Chen G; Tan ML; Li KK; Leung PC; Ko CH
    J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of uric acid-lowering agents limits experimental cyclosporine nephropathy.
    Mazali FC; Johnson RJ; Mazzali M
    Nephron Exp Nephrol; 2012; 120(1):e12-9. PubMed ID: 22126908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease.
    Ponticelli C; Podestà MA; Moroni G
    Kidney Int; 2020 Nov; 98(5):1149-1159. PubMed ID: 32650020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
    Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
    J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperuricemia and Progression of Chronic Kidney Disease: Role of Phenotype Transition of Renal Tubular and Endothelial Cells.
    Kang DH
    Contrib Nephrol; 2018; 192():48-55. PubMed ID: 29393109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uric Acid, Vascular Stiffness, and Chronic Kidney Disease: Is There a Link?
    Ramirez-Sandoval JC; Sanchez-Lozada LG; Madero M
    Blood Purif; 2017; 43(1-3):189-195. PubMed ID: 28114139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid and chronic kidney disease: which is chasing which?
    Johnson RJ; Nakagawa T; Jalal D; Sánchez-Lozada LG; Kang DH; Ritz E
    Nephrol Dial Transplant; 2013 Sep; 28(9):2221-8. PubMed ID: 23543594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
    Filiopoulos V; Hadjiyannakos D; Vlassopoulos D
    Ren Fail; 2012; 34(4):510-20. PubMed ID: 22260409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.